ASTH (Astrana Health) Other Operating Expense: $54 Mil (TTM As of Mar. 2026)


ASTH Astrana Health Inc ASTH
87 GF Score
Price $46.41
GF Value $82.55
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Other Operating Expense?

Astrana Health ASTH +3.09% 87 Other Operating Expense is $54 Mil as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.55 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Astrana Health's Other Operating Expense for the three months ended in Mar. 2026 was $15 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $54 Mil.

Astrana Health's quarterly Other Operating Expense increased from Sep. 2025 ($16 Mil) to Dec. 2025 ($16 Mil) but then declined from Dec. 2025 ($16 Mil) to Mar. 2026 ($15 Mil).

Astrana Health's annual Other Operating Expense increased from Dec. 2023 ($18 Mil) to Dec. 2024 ($28 Mil) and increased from Dec. 2024 ($28 Mil) to Dec. 2025 ($46 Mil).

Astrana Health Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Astrana Health's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Other Operating Expense Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.52 17.54 17.75 27.93 45.75

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.85 6.90 15.60 16.40 15.48
ASTH
87GF Score
Astrana Health Inc ASTH
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $54 Mil mean?
Astrana Health (ASTH) has a Other Operating Expense of $54 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Astrana Health and its competitors.
Is Astrana Health's Other Operating Expense too high?
Astrana Health's current Other Operating Expense is $54 Mil. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Other Operating Expense compare to SGRY and SEM?
Astrana Health's Other Operating Expense of $54 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Astrana Health and its competitors. Astrana Health's current Other Operating Expense is $54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.55, compared to a current price of $46.41 — trading 43.8% below its estimated fair value. The current Other Operating Expense is $54 Mil. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Astrana Health (ASTH), the current Other Operating Expense is $54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $46.41 is trading 43.8% below its estimated GF Value™ of $82.55. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Other Operating Expense: $54 Mil
  • GF Value™: $82.55 vs. price of $46.41 (43.8% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$46.41
Price
$82.55
GF Value